Publication | Closed Access
Radioimmunotherapy for advanced breast cancer using I-131-ChL6 antibody.
60
Citations
0
References
1997
Year
Objective clinical responses were seen in five of 10 patients treated with 131I-ChL6. The tumor response in heavily pretreated, advanced breast cancer may be related to the combined effects of targeted radiation and the biological activity of L6/ChL6.